DISINFO: Big Pharma tested cancer-causing drug on Ukrainians
In 2013-2014, a phase III study of the drug under the code SB4 actually took place in a number of EU countries, South America and Ukraine - patients used an already well-studied safe drug that was potentially effective against their disease. Using this code, you can find detailed information about the goals and results of this study in open clinical trial databases (The European Union Clinical Trials Register, Good Clinical Practice Network). The purpose of the study was to compare the effectiveness of the drug SB4 and the drug Enbrel in patients who have moderate to severe rheumatoid arthritis.

